Physicians

Robert M. Barone, D.O.
Dr. Robert M. Barone, M.D.

Clinical Specialty:  Oncologic Surgery

 

Current Title:
  • Director of Surgical Oncology, Sharp Healthcare
  • Clinical Investigator, Sharp Clinical Oncology Research
  • Executive Committee, Society of Surgical Oncology

Board Certifications: American Board of Surgery

Licensure: California

 

Areas of Clinical Interest: 
  • Cytoreductive surgery and HIPEC for Gastrointestinal tract tumors,
    Mesothelioma, Sarcoma and Gynecological Cancers
  • Breast, Endocrine, Pancreas, and Melanoma Surgery
  • Gastrointestinal Oncology Surgery
  • Sentinel Node Mapping of Breast and Melanoma Cancers
  • Ovarian Oncology Surgery and Intraperitoneal Chemotherapy
  • Liver Cancer Surgery

Honors:
  • Chicago Surgical Society Award for Surgical Research
  • SAMA-UTMB National Research Forum Award
  • Sigma Xi Roswell Park Memorial Fellowship

Fellowship: 
  • Surgical Oncology, University of Illinois
  • American Cancer Society Clinical Fellowship
  • University of Illinois at the Medical Center, Masters Degree (Surgery)
  • Roswell Park Cancer Institute Fellowship

 

Residency: General Surgery, University of Illinois

 

Internship: General Surgery, University of Illinois

 

Medical School: State University of New York Medical School, Buffalo

 

Professional Associations: 
  • Fellow, American College of Surgeons
  • Society of Surgical Oncology
  • American Society of Clinical Oncology
  • American Head and Neck Society
  • Society of Surgery of the Alimentary Tract
  • San Diego Medical Society
  • California Medical Association

 

Publications: Multiple Articles in Peer Review Journals, Book Chapters, Oral and Video Tape Presentations on Cancer-Related Subjects.


Research: 

Developed implantable liver infusion pumps and implantable venous access devices,

Developed combination therapy of liver resection and intra-arterial chemotherapy.

Cytoreductive surgery for GI tract tumors, ovarian, colorectal, and appendiceal cancers combined with intraoperative and immediate postoperative intraperitoneal chemotherapy.

Past principal investigator of NIH grants.